John Wyllie Coburn
#116,713
Most Influential Person Now
John Wyllie Coburn's AcademicInfluence.com Rankings
John Wyllie Coburnphilosophy Degrees
Philosophy
#5104
World Rank
#7829
Historical Rank
Logic
#2437
World Rank
#3427
Historical Rank
Download Badge
Philosophy
John Wyllie Coburn's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is John Wyllie Coburn Influential?
(Suggest an Edit or Addition)John Wyllie Coburn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. (2003) (2521)
- NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. (1991) (442)
- Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. (2005) (414)
- Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. (1981) (394)
- The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. (1982) (343)
- Protein losses during peritoneal dialysis. (1981) (339)
- Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. (2005) (337)
- Methods for assessing nutritional status of patients with renal failure. (1980) (332)
- Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. (1989) (313)
- Bone aluminum and histomorphometric features of renal osteodystrophy. (1982) (279)
- The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. (2002) (277)
- Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. (1982) (275)
- Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects. (1973) (271)
- Histological quantitation of aluminum in iliac bone from patients with renal failure. (1982) (258)
- Acute interstitial nephritis due to methicillin. (1978) (251)
- Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. (1968) (249)
- Glucose absorption during continuous ambulatory peritoneal dialysis. (1981) (246)
- Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. (1976) (239)
- Transplantation of Cadaveric Kidneys from Patients with Hepatorenal Syndrome (1969) (239)
- The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. (2003) (231)
- Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man. (1972) (231)
- Renal artery embolism: clinical features and long-term follow-up of 17 cases. (1978) (219)
- Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. (1983) (216)
- changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms. (1972) (207)
- Magnesium, the mimic/antagonist to calcium. (1984) (193)
- Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism. (1975) (190)
- Study of intestinal absorption of calcium in patients with renal failure. (1973) (189)
- Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. (1991) (187)
- A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. (2000) (177)
- Aluminum loading during total parenteral nutrition. (1982) (175)
- Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. (2004) (173)
- Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. (2004) (168)
- Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3. (1976) (164)
- BONE DISEASE ASSOCIATED WITH TOTAL PARENTERAL NUTRITION (1980) (163)
- Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. (1981) (163)
- Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. (1988) (162)
- 1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure. (1974) (160)
- Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. (2005) (154)
- Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. (1984) (153)
- METABOLIC STUDIES OF LOW PROTEIN DIETS IN UREMIA: I. NlTEOGEN AND POTASSIUM (1973) (144)
- Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation. (1969) (140)
- 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy. (1974) (135)
- Vitamin D. Basic research and its clinical application. (1979) (132)
- Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism. (1997) (129)
- Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure. (1972) (127)
- The physicochemical state and renal handling of divalent ions in chronic renal failure. (1969) (124)
- Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism (2000) (121)
- Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison. (2001) (121)
- Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions. (1985) (119)
- Amyloid syndromes associated with hemodialysis. (1989) (118)
- Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism. (1984) (118)
- Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms. (1970) (118)
- Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats. (1972) (117)
- Divalent ion metabolism in patients with acute renal failure: studies on the mechanism of hypocalcemia. (1974) (116)
- An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. (2008) (114)
- Candida peritonitis. Report of 22 cases and review of the English literature. (1976) (112)
- Effect of MgCl2 infusion on urinary Ca and Na during reduction in their filtered loads. (1967) (111)
- Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. (1982) (111)
- Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. (2000) (102)
- Evidence for suppression of parathyroid gland activity by hypermagnesemia. (1970) (102)
- Vascular calcification and peripheral necrosis in a renal transplant recipient. Reversal of lesions following subtotal parathyroidectomy. (1970) (100)
- Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. (1969) (97)
- METABOLIC STUDIES OF LOW PROTEIN DIETS IN UREMIA: II. CALCIUM, PHOSPHOKUS AND MAGNESIUM (1973) (97)
- Renal bicarbonate wasting during phosphate depletion. A possible cause of altered acid-base homeostasis in hyperparathyroidism. (1973) (96)
- Bone disease in burn patients (1993) (96)
- The hormonal and non-hormonal control of renal excretion of calcium and magnesium. (1973) (91)
- The influence of extracellular volume expansion on renal phosphate reabsorption in the dog. (1969) (91)
- Excretion of phosphate and calcium. Physiology of their renal handling and relation to clinical medicine. (1973) (91)
- Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. (1988) (90)
- Comparison of model and experiment for Ar, Ar/O2 and Ar/O2/Cl2 inductively coupled plasmas (2006) (88)
- Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. (1986) (85)
- Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease. (1973) (83)
- Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis. (1986) (83)
- Early deposition of aluminum in bone in diabetic patients on hemodialysis. (1987) (83)
- Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. (1976) (82)
- Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis. (1981) (82)
- Intestinal absorption of calcium and the effect of renal insufficiency. (1973) (80)
- Role of serum Ca, parathyroid hormone, and NaCl infusion on renal Ca and Na clearances. (1968) (77)
- Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis. (1984) (76)
- Hypocalcemia in magnesium-depleted dogs: evidence for reduced responsiveness to parathyroid hormone and relative failure of parathyroid gland function. (1974) (76)
- Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy. (1987) (73)
- Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets. (1973) (73)
- Use of calcium carbonate as a phosphate binder in dialysis patients. (1986) (73)
- Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease. (1963) (72)
- Parenteral aluminum administration in the dog: I. Plasma kinetics, tissue levels, calcium metabolism, and parathyroid hormone. (1984) (72)
- TURNOVER OF ENDOGENOUS PARATHYROID HORMONE IN UREMIC PATIENTS AND THOSE UNDERGOING HEMODIALYSIS (1972) (71)
- Aluminum as a factor in the bone disease of long-term parenteral nutrition. (1982) (71)
- Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide. (1991) (70)
- Renal handling of magnesium in the dog. (1969) (70)
- Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia. (1983) (70)
- Optimal dietary protein treatment during chronic hemodialysis. (1969) (70)
- Reduced Serum Levels of Iα, 25-Dihydroxyvitamin D During Long-term Total Parenteral Nutrition (1981) (67)
- Hepatic aluminum accumulation in children on total parenteral nutrition. (1984) (66)
- Calcium and inorganic phosphate transport in rat colon: dissociated response to 1,25-dihydroxyvitamin D3. (1980) (63)
- Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy. (1990) (63)
- "High-dose" calcitriol for control of renal osteodystrophy in children on CAPD. (1987) (60)
- Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH. (1986) (60)
- The acute effect of adrenal steroids on the interrelationship between the renal excretion of sodium, calcium, and magnesium. (1967) (60)
- Studies on mechanisms of hypocalcemia of magnesium depletion. (1973) (59)
- Studies on calciferol metabolism. VII. The renal production of the biologically active form of vitamin D, 1,25-dihydroxycholecalciferol; species, tissue and subcellular distribution. (1973) (59)
- Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients. (1990) (58)
- Effect of metabolic acidosis in intestinal absorption of calcium and phosphorus. (1980) (58)
- Thiazide-lnduced Rise in Serum Calcium and Magnesium in Patients on Maintenance Hemodialysis (1970) (58)
- Abnormalities of the musculoskeletal system in hemodialysis patients. (1975) (57)
- Controlled comparison of 20-g and 40-g protein diets in the treatment of chronic uremia. (1968) (56)
- Bone histomorphometry of renal osteodystrophy in diabetic patients (1987) (56)
- Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and "epidemic" forms of the syndrome. (1985) (55)
- Actions of 1 alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus. (1977) (54)
- The use of 1,25-dihydroxyvitamin D3 in early renal failure. (1992) (51)
- Acute renal failure in diabetic patients after intravenous infusion pyelography. (1973) (50)
- Osteomalacia and bone disease arising from aluminum. (1986) (50)
- The acute effects of 1,25-dihydroxycholecalciferol on serum immunoreactive parathyroid hormone in the dog. (1979) (50)
- Metabolic bone disease associated with total parenteral nutrition. (1984) (50)
- Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure. (1978) (49)
- Effect of chronic metabolic acidosis on vitamin D metabolism in humans. (1983) (49)
- Aluminum and renal osteodystrophy. (1986) (48)
- Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group. (1998) (46)
- Pharmacokinetics and biologic effects of calcitriol in normal humans. (1985) (46)
- Controlled comparison of hemodialysis and peritoneal dialysis: Veterans Administration multicenter study. (1984) (45)
- IgG antibodies against bovine serum albumin in humans--their prevalence and response to exposure to bovine serum albumin. (2005) (45)
- Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient? (1987) (45)
- Microradiographic studies of bone in renal osteodystrophy. (1969) (45)
- Applications of the Redy sorbent system to hemodialysis and peritoneal dialysis. (2008) (44)
- Control of serum phosphorus in uremia. (1989) (44)
- The effect of calcium infusion on renal handling of magnesium with normal and reduced glomerular filtration rate. (1970) (43)
- Interactions between vitamin D deficiency and phosphorus depletion in the rat. (1979) (43)
- Evaluation of chronic uremia. Importance of serum urea nitrogen, serum creatinine, and their ratio. (1974) (43)
- Bone histologic response to deferoxamine in aluminum-related bone disease. (1987) (43)
- Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. (1993) (42)
- Calcium-sensing receptor and calcimimetic agents. (1999) (42)
- A controlled evaluation of clinical and metabolic effects of dialysate calcium levels during regular hemodialysis. (1971) (42)
- Acute actions of 1,25-dihydroxy-vitamin D3 in normal man: effect on calcium and parathyroid status. (1977) (41)
- Surgical management of secondary hyperparathyroidism. (1972) (41)
- Prevention of metabolic bone disease in the pre-end-stage renal disease setting. (1998) (41)
- Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure. (1980) (41)
- Early renal brush border membrane adaptation to dietary phosphorus. (1984) (40)
- Absorption and action of insulin added to peritoneal dialysate in dogs. (1979) (40)
- Destructive Spondyloarthropathy of the Cervical Spine in Patients With Chronic Renal Failure (1997) (39)
- Intestinal and metabolic effect of 1,25-dihydroxyvitamin D3 in normal adult rat. (1981) (39)
- Prevention of phosphate retention and hyperphosphatemia in uremia. (1987) (38)
- Hypercalcemia in reticulum cell sarcoma without hyperparathyroidism of skeletal metastases. (1973) (38)
- Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis. (1989) (38)
- Biological activity of 24,25-dihydroxycholecalciferol in chicks and rats. (1976) (38)
- Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism. (2000) (37)
- Effects of 1α,25-,24R,25-, and 1α,24R,25-hydroxylated metabolites of vitamin D3on calcium and phosphate absorption by duodenum from intact and nephrectomized rats (1977) (37)
- Acid-base status during the interdialytic period in patients maintained with chronic hemodialysis. (1969) (35)
- METABOLIC BONE DISEASE IN TOTAL PARENTERAL NUTRITION (1981) (35)
- The problem and unanswered questions. Renal osteodystrophy, soft tissue calcification, and distrubed divalent ion metabolism in chronic renal failure. (1969) (34)
- Effect of acute and long-standing hypocalcemia on blood pressure and plasma renin activity in man. (1974) (34)
- Changes in bone histology after treatment with desferrioxamine. (1986) (34)
- Renal adaptation to phosphorus deprivation: Characterization of early events (1986) (33)
- Prostaglandins: effect on plasma calcium concentration. (1973) (32)
- Effect of NaCl infusion on urinary Ca++ and Mg++ during reduction in their filtered loads. (1967) (32)
- Aluminum and renal failure (2011) (31)
- Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine. (1986) (31)
- The interrelationship between sodium, calcium, and magnesium excretion in advanced renal failure. (1969) (30)
- A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to viatamin D. (1980) (30)
- Aluminum removal by peritoneal dialysis: intravenous vs. intraperitoneal deferoxamine. (1986) (30)
- Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia. (1983) (30)
- Calcific periarthritis and hemodialysis. (1973) (29)
- Beta2-microglobulin deposition in bone in chronic renal failure (1991) (29)
- Clearance of aluminum by hemodialysis: effect of desferrioxamine. (1986) (28)
- Calcimimetic agents and the calcium-sensing receptor. (2000) (28)
- Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis. (1974) (28)
- 24,25-dihydroxy-cholecalciferol, a vitamin D sterol with qualitatively unique effects in uremic man (1979) (28)
- Biological effects of aluminum on normal dogs: studies on the isolated perfused bone. (1987) (28)
- STUDIES OF EXPERIMENTAL RENAL FAILURE IN DOGS. I. EFFECT OF 5-6 NEPHRECTOMY ON CONCENTRATING AND DILUTING CAPACITY OF RESIDUAL NEPHRONS. (1965) (28)
- Advances in vitamin D metabolism as they pertain to chronic renal disease. (1976) (28)
- Renal Osteodystrophy and Maintenance Dialysis (1983) (27)
- Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide. (1988) (27)
- Oral and parenteral calcitriol for the management of end-stage renal disease. (1991) (26)
- Effect of metabolic acidosis on phosphate transport by the renal brush-border membrane. (1983) (26)
- Infantile vitamin D-resistant rickets associated with total parenteral nutrition. (1982) (26)
- 1α-Hydroxy-vitamin D2: a new look at an ‘old’ compound (1996) (25)
- Recurrent glomerulonephritis due to anti-glomerular basement membrane-antibodies in two successive allografts. (1973) (25)
- The clinical physiology of calcium homeostasis, parathyroid hormone an, and calcitonin. I. (1971) (25)
- Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis. (1970) (25)
- Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis. (1987) (25)
- Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy. (1980) (25)
- The calcimimetic agents: perspectives for treatment. (2002) (24)
- Interaction of somatostatin with PTH and AVP: renal effects. (1979) (24)
- Evaluating modified protein diets for uremia. (1969) (24)
- Effects of vitamin D and diet magnesium on magnesium metabolism. (1980) (24)
- Relationship between the kidney and parathyroid hormone. (1975) (23)
- Granulomatous sarcoid nephritis. (1967) (23)
- Renal action of cholera toxin: I. Effects on urinary excretion of electrolytes and cyclic AMP. (1975) (23)
- 30 Calcium and Phosphorus Metabolism and Bone Disease in Uremia (1970) (22)
- Metabolic balance study of plasmapheresis in a case of Waldenstrom's macroglobulinemia. (1962) (22)
- Maintenance peritoneal dialysis as an alternative in the patient with diabetes mellitus and end-stage uremia. (1974) (22)
- Parenteral nutrition: effect on bone and mineral homeostasis. (1991) (22)
- Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure. (1974) (21)
- Effect of phosphorus depletion on intestinal calcium and phosphorus absorption. (1979) (21)
- Iliac crest bone biopsy for diagnosis of aluminum toxicity and a guide to the use of deferoxamine. (1986) (20)
- Mechanism of the Antidiuretic Effect of ß-Adrenergic Stimulation in Man (1976) (20)
- End-stage renal failure. (1978) (20)
- Use of active vitamin D sterols in patients with chronic kidney disease, stages 3 and 4. (2003) (19)
- Impaired calcium absorption in uremic man: evidence for defective absorption in the proximal small intestine (1974) (19)
- Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy. (1977) (19)
- Total parenteral nutrition and its effects on bone metabolism. (1994) (19)
- Renal failure following methylglucamine diatrizoate (renografin) aortography: report of a case with unilateral renal artery stenosis. (1966) (18)
- Intestinal Absorption of Calcium: Its Assessment, Normal Physiology, and Alterations in Various Disease States (1982) (17)
- Renal osteodystrophy: some new questions on an old disorder. (1988) (17)
- Intestinal phosphate absorption in normal and uremic man: effects of 1,25(OH)2-vitamin D3 and 1alpha(OH)-vitamin D3. (1977) (17)
- Intestinal absorption of calcium: role of dietary phosphate and vitamin D. (1981) (17)
- Renal Osteodystrophy in Children Undergoing Continuous Ambulatory Peritoneal Dialysis (1984) (17)
- On the mechanism and nature of the defect in intestinal absorption of calcium in uremia. (1975) (17)
- Nutritional management of the adult patient undergoing peritoneal dialysis. (1978) (16)
- The biochemical indices of experimental phosphorus depletion (PD): a re-examination of their physiological implications. (1978) (16)
- Prospective evaluation of aluminum loading from formula in infants with uremia. (1990) (16)
- Biologic action of 1,25-dihydroxy-vitamin D3 in the rachitic dog. (1973) (15)
- Role of Aluminum Accumulation in Renal Osteodystrophy (1984) (15)
- Calcifediol in Chronic Renal Insufficiency (1976) (14)
- Influence of dietary magnesium in experimental phosphate depletion: bone and soft tissue mineral changes. (1979) (14)
- A model of renal insufficiency in the chick. (1972) (14)
- Rapid appearance of hypercalcemia with initiation of hemodialysis. (1969) (14)
- Effect of Renal Denervation and a-Adrenergic Blockade on Sodium Excretion in Dogs with Chronic Ligation of the Common Bile Duct 1 (1974) (14)
- The disappearance of intractable pruritus after parathyroidectomy in uremic patients with secondary hyperparathyroidism. (1968) (13)
- Modification of calciuretic effect of extracellular volume expansion by phosphate infusion. (1971) (13)
- Effect of potassium depletion on response to acute heat exposure in unacclimatized man. (1966) (13)
- Renal concentrating defect in canine radiation nephritis. (1966) (13)
- Control of Hyperphosphatemia in Chronic Renal Failure (1990) (12)
- An update on vitamin D as related to nephrology practice: 2003. (2003) (12)
- Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels. (1987) (12)
- The effect of calcemic disorders and uremia on the mineral content of skin. (1971) (12)
- Toxic effects of aluminum in end-stage renal disease: discussion of a case. (1988) (11)
- Plasma aluminum levels in pediatric dialysis patients: comparison of hemodialysis and continuous ambulatory peritoneal dialysis. (1987) (11)
- Registry on mucormycosis in dialysis patients. (1989) (11)
- Calcium deprivation and renal handling of calcium during repeated saline infusions. (1971) (11)
- Calcitriol in the Management of Renal Osteodystrophy (1996) (11)
- Renal osteodystrophy in end-stage renal failure. (1978) (10)
- Beta 2-microglobulin deposition in bone in chronic renal failure. (1991) (10)
- Development of a sorbent peritoneal dialysate regeneration system--a progress report. (1978) (10)
- The role of vitamin D in idiopathic hypercalciuria. (1979) (10)
- Normophosphatemic phosphate depletion in growing rat. (1979) (10)
- Spontaneous Variations in Electrolyte Excretion in the Awake Dog 1 2 (1974) (10)
- 1 alpha-Hydroxy-vitamin D2: a new look at an 'old' compound. (1996) (9)
- Measurement of dialysance and bi-directional fluxes of calcium in vivo using radiocalcium. (1971) (9)
- Spurious hypocalcemia in patients undergoing maintenance hemodialysis. (1969) (9)
- Severe hypokalaemic metabolic alkalosis following ingestion of gaviscon® (2007) (9)
- Useful function of "non-functioning" renal homograft. (1975) (9)
- The scintillation camera in embolic acute renal failure. (1970) (9)
- Efficacy and safety of intermittent oral 1α(OH)-vitamin D2 in suppressing 2° hyperparathyroidism in hemodialysis patients (1997) (9)
- PLASMA KINETICS OF INTRAVENOUS CALCITRIOL IN NORMAL AND DIALYSED SUBJECTS AND ACUTE EFFECT ON SERUM nPTH LEVELS. (1988) (9)
- The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. I. (1971) (9)
- Medical treatment in primary and secondary hyperparathyroidism. (1972) (9)
- Hypernatremic, hyperosmolar coma complicating chronic peritoneal dialysis. (1974) (9)
- Isosorbide: effects on renal function, renal clearance and tubular handling and volume of distribution in dogs. (1967) (9)
- Calcium infusion test in renal failure. (1970) (9)
- Pathophysiology of calcium, phosphorus, and magnesium (1981) (8)
- Clinical trial with oral carbohydrate supplement in hemodialysis patients: A nutritional evaluation (1983) (8)
- Achievement of proposed NKF-K/DOQI Bone Metabolism and Disease targets Treatment with cinacalcet HCl in dialysis patients with uncontrolled secondary hyperparathyroidism (2003) (8)
- Bone disease in uremia. (1983) (8)
- The effect of chronic metabolic acidosis on the end organ responsiveness to parathyroid hormone in man. (1983) (8)
- The effects of aluminum loading on the renal response to parathyroid hormone in the vitamin D-replete rat. (1986) (8)
- STUDIES OF EXPERIMENTAL RENAL FAILURE IN DOGS. II. EFFECT OF FIVE-SIXTHS NEPHRECTOMY ON SODIUM-CONSERVING ABILITY OF RESIDUAL NEPHRONS. (1964) (8)
- Effects of Sucralfate and Ranitidine on Aluminum Concentrations in Elderly Volunteers (1995) (8)
- Bone mineral metabolism and osteodystrophy in uremia. (1968) (8)
- Calciferol metabolism and intestinal calcium transport in the chick with reduced renal function. (1974) (8)
- Potassium Depletion in Heat Stroke : A Possible Etiologic Factor. (1966) (7)
- Relationship between urinary calcium and calcium intake during calcitriol administration. (1986) (7)
- Protein nutrition in uremia: a review. (1968) (7)
- Postinfectious glomerulonephritis in a renal allograft associated with a mycotic aneurysm of a coronary artery. (1984) (7)
- Divalent Ion Metabolism (1978) (7)
- Unique effects of 24,25-dihydroxyvitamin D3 in uremic patients. (1980) (7)
- Uses and actions of 1,25-dihydroxyvitamin D[3] in uremia (1980) (7)
- Intermittent oral 1 a-hydroxyvitamin D 2 is e ff ective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients (1998) (7)
- 1,25-Dihydroxyvitamin D3 stimulates calcium and phosphate absorption by different mechanisms: contrasting requirements for sodium. (1984) (6)
- Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition. (1981) (6)
- Renal osteodystrophy. (1980) (6)
- The effect of hydrochlorothiazide administration on serum and urinary calcium in normal, hypoparathyroid and hyperparathyroid subjects. Studies on mechanisms. (1971) (6)
- Comments on the mechanisms of disordered divalent ion metabolism in renal failure. A possible role of magnesium depletion. (1970) (6)
- Mucormycosis among patients on dialysis. (1989) (6)
- EFFECT OF UREA OSMOTIC DIURESIS ON POTASSIUM EXCRETION. (1964) (5)
- EARLY RENAL FAILUREl (1992) (5)
- Effect of vitamin D sterols and dietary magnesium on calcium and phosphorous homeostasis. (1981) (5)
- Homeostasis and action of parathyroid hormone in normal man and patients with mild renal failure. (1975) (5)
- Impaired vitamin D metabolism in acute uremia. (1977) (5)
- Action of 1,25-dihydroxycholecalciferol in normal and uraemic man. (1973) (5)
- Postinfectious glomerulonephritis in a renal allograft associated with a mycotic aneurysm of a coronary artery (1984) (5)
- BIOAVAILABILITY OF CALCITRIOL AFTER ORAL, INTRAVENOUS AND INTRAPERITIONEAL DOSES IN DIALYSIS PATIENTS. (1988) (5)
- Role of growth hormone in experimental phosphorus deprivation in the rat (2006) (5)
- Early renal adaptation to dietary phosphorus restriction. (1984) (4)
- Chronic peritoneal dialysis for the management of chronic renal failure. (1973) (4)
- Management of bone disease in the dialysis patient. (1985) (4)
- Nephrotoxicity Associated with Use of Methoxyflurane (1974) (4)
- Mechanism of the antidiuretic effect of beta-adrenergic stimulation in man. (1976) (3)
- Vitamin D: Normal Physiology and Vitamin D Therapeutics in Normal Nutrition and Various Disease States (2002) (3)
- Intestinal and parathyroid calcium-binding proteins in the dog. Comparison of biochemical properties and responses to vitamin D. (1980) (3)
- Scalene lymph node involvement in primary and disseminated coccidioidomycosis. Evidence of extrapulmonary spread in primary infection. (1962) (3)
- Effects of 1 alpha,25-, 24R,25-, and 1 alpha,24R,25-hydroxylated metabolites of vitamin D3 on calcium and phosphate absorption by duodenum from intact and nephrectomized rats. (1977) (2)
- Hypercalcemic Response to Hydrochlorothiazide in Uremia: Evidence for an Extrarenal Effect on Calcium Metabolism. (1970) (2)
- Studies of the probable sites and nature of calcium malabsorption in uremic patients and those undergoing hemodialysis. (1972) (2)
- Renal osteodystrophy. (1984) (2)
- Interactions between Vitamin D and the Kidney (1976) (2)
- Pathophysiology and treatment of uremic bone disease (1983) (2)
- Editorial: Role of the kidney in the metabolism of calciferol (vitamin D). (1973) (2)
- Faraday-rotation studies of CaF2:Eu (1970) (2)
- 26 – Renal Bone Diseases (1999) (2)
- CHAPTER 40 – Renal Bone Diseases: Clinical Features, Diagnosis, and Management (2001) (1)
- Interactions between treatment with 1,25(OH)2D3 and glucocorticoids in uremic patients after kidney transplantation. (1980) (1)
- Aluminum-Containing Phosphate Binding Agents and Plasma Aluminum Levels in Children Undergoing CAPD: Preliminary Results with the Use of Calcium Carbonate (1985) (1)
- Risk factors for aluminum toxicity and its prevention (1990) (1)
- Disorders of Magnesium Homeostasis and Magnesium in Therapy (1998) (1)
- Bone disease in burn patients: Roles of aluminum and bed rest (1992) (1)
- The Effect of Vitamin D3 and Metabolites on Magnesium Metabolism (1979) (1)
- The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II. (1971) (1)
- Acute renal failure, Viet Nam, 1965: transglobal treatment. (1965) (1)
- Nephrotoxicity associated with use of methoxyflurane. Recovery following severe renal impairment. (1974) (1)
- Rickets and osteopenia with normal 25OH vitamin D levels in infants on parenteral nutrition. (1980) (1)
- Gut absorption of calcium: interactions between phosphate and vitamin D. (1980) (1)
- On transcalciferin, the serum binding protein for 25-hydroxycholecalciferol (1977) (1)
- Evolution of Renal Osteodystrophy and the Effect of High-Dose Calcitriol in Children Undergoing CAPD (1985) (1)
- PREOPERATIVE LOCALIZATION OF PARATHYROID ADENOMAS BY TECHNETIUM‐THALLIUM AND ULTRASOUND IMAGING (1984) (1)
- Hypercalcemia During Treatment of Uremic Patients with 1,25(OH)2D3: Analysis of 43 Cases (1979) (1)
- Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: value of bone biopsy in the diagnosis and management. (1995) (0)
- Ischemic Vascular Necrosis Associated with Uremic Hyperparathyroidism. (1972) (0)
- EFFECTS OF 1,25-DIHYDROXYCHOLECALCIFEROL IN PATIENTS WITH CHRONIC RENAL-FAILURE IN OXFORD REGION (1973) (0)
- CALCITRIOL IN EARLY AND PRE-DIALYSIS RENAL FAILURE: WHAT ARE THE RISKS AND BENEFITS? (1991) (0)
- Evaluating Modified Protein Diets for Uremia1 (1969) (0)
- Letter: Calcifediol in chronic renal insufficiency. (1976) (0)
- Blood Pressure Effects of Acute Hypercalcemia (2020) (0)
- Tenckhoff Catheter for Long-term Peritoneal Dialysis (1974) (0)
- ALUMINUM-RELATED HONE DISEASE AND SERUM ALUMINUM IN CHILDREN UNDERGOING CAPD (1984) (0)
- Correction: Symposium Article on Calcium-Regulating Hormones (1981) (0)
- Comparison of intravenous with oral one-alpha-hydroxyvitamin D2 in hemodialysis patients with secondary hyperparathyroidism (1998) (0)
- Bone and Mineral Disturbances in Renal Insufficiency (1983) (0)
- Severe Infections in Renal Homotransplant Recipients. (1969) (0)
- Letter: Vitamin D and calcium homeostasis. (1974) (0)
- NephrologyDialysis Transplantation la-Hydroxy-vitamin D2: a new look at an 'old' compound (2005) (0)
- Kidney stones. (1980) (0)
- Clinical Pharmacology and Application of the Active Forms of Vitamin D (1979) (0)
- The statistical and thermodynamic theory of thermal radiation and its application to detector sensitivity. (1958) (0)
- Studies on antisera against vitamin D-metabolites (1979) (0)
- Book Reviews / Varia (1976) (0)
- Recent advances in the endocrinology of vitamin D and implications for renal failure. (1978) (0)
- Renal Artery Embolism (2020) (0)
- Proceedings: Recurrent glomerulonephritis. (1974) (0)
- Rickets and Deficiency of Vitamin D Metabolites-Reply (1982) (0)
- Are the cytosolic binding proteins for 25-hydroxycholecalciferol artifacts? (1977) (0)
- LOW SERUM CALCITRIOL CONCENTRATIONS AND REDUCED BONE FORMATION IN PATIENTS WITH SEVERE BURNS (1991) (0)
- Consultant List (2002) (0)
- OF l,25(0H)2-VITAMIN 03 ANO la(OH)-VITAMIN 03 (1977) (0)
- Efficacy of 1α(OH)-vitamin D2 in suppressing 2° hyperparathyroidism in hemodialysis patients (1996) (0)
- Introduction to Calcium Symposium (1973) (0)
- Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy. (1978) (0)
- Immunopathologic studies of repeated recurrent glomerulonephritis in an allograft recipient. (1972) (0)
- Title Page / Contents / Foreword (1980) (0)
- Book Reviews–Livres Nouveaux (1969) (0)
This paper list is powered by the following services:
